Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

35.340
-1.380-3.76%
Volume:18.34M
Turnover:648.44M
Market Cap:214.30B
PE:32.56
High:36.620
Open:36.060
Low:35.000
Close:36.720
52wk High:43.939
52wk Low:27.882
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.06
T/O Rate:0.30%
Dividend:0.49
Dividend Rate:1.40%
EPS(LYR):1.085
ROE:19.40%
ROA:9.08%
PB:4.86
PE(LYR):32.56
PS:11.55

Loading ...

Hansoh Pharma says China regulator accepts NDA for HS-10568 injection in kidney disease complication

Reuters
·
Jun 10

Hansoh Pharmaceutical - Nda for Hs-10,568 Injection Accepted by Nmpa of China for Shpt in Adult Ckd Patients

THOMSON REUTERS
·
Jun 10

HANSOH PHARMA Announces Appointment of Guo Ying as Joint Company Secretary

Stock News
·
Jun 10

Hansoh Pharmaceutical Group Stock Rises 2.6% in Hong Kong

Dow Jones
·
Jun 10

Hansoh Pharmaceutical Group Stock Falls 1.8% in Hong Kong

Dow Jones
·
Jun 08

Hansoh Pharmaceutical Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
Jun 05

HANSOH PHARMA Shares Surge on New Drug Application Acceptance

Stock News
·
Jun 05

Hansoh Pharma seeks shareholder approval for 2026 share option and award scheme

Reuters
·
Jun 04

Hansoh Pharma announces annual general meeting notice

Reuters
·
Jun 04

Hansoh Pharmaceutical's Weight-loss Injection Enters China Review

MT Newswires Live
·
Jun 04

BRIEF-Hansoh Pharmaceutical Says NDA For Olatorepatide Injection Accepted By China's NMPA

Reuters
·
Jun 04

HANSOH PHARMA's Obesity Drug Application Accepted by Chinese Regulator

Stock News
·
Jun 04

Hansoh Pharma says China regulator accepts NDA for olatorepatide weight management injection

Reuters
·
Jun 04

Hansoh Pharmaceutical - Nda for Olatorepatide Injection Accepted by Nmpa of China for Chronic Weight Management

THOMSON REUTERS
·
Jun 04

Hansoh Pharmaceutical Group Stock Sheds 2.3% in Hong Kong

Dow Jones
·
Jun 03

Hansoh Pharmaceutical Group Stock Sheds 7.1% in Hong Kong

Dow Jones
·
May 28

Innovative Drug Stocks Decline in Hong Kong Amid Rate Hike Expectations and ASCO Conference Focus

Stock News
·
May 28

Movement Alert|Hansoh Pharmaceutical Falls 6.04% in Regular Trading, Trading at 31.9 HKD

Market Focus
·
May 28

Hansoh Pharmaceutical Group’s Valuation After HS-10541 Clinical Trial Approval For KRAS G12C Tumors

Simply Wall St.
·
May 27

BUZZ-J&T Global Express leads gain in newcomers to Hang Seng Index

Reuters
·
May 26